Our mission is to advance AI and genomic technologies to enable personalized diagnosis and treatment for complex diseases, especially cancer and neuropsychiatric disorders like depression and schizophrenia. We focus on developing and combining AI with biological techniques, including reliable, explainable machine learning and single-cell spatial transcriptomics. Our research is highly interdisciplinary, spanning AI, data science, molecular biology, genetics, genomics, and neuroscience